136 related articles for article (PubMed ID: 3851693)
21. Dissociation between cytostatic and cytolytic activity of human monocytes towards K-562 cells.
Eggen BM; Lamvik JO
Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):261-4. PubMed ID: 6516853
[TBL] [Abstract][Full Text] [Related]
22. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
[TBL] [Abstract][Full Text] [Related]
23. Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use.
Kuroki H; Morisaki T; Matsumoto K; Onishi H; Baba E; Tanaka M; Katano M
Cancer Immunol Immunother; 2003 Sep; 52(9):561-8. PubMed ID: 14627128
[TBL] [Abstract][Full Text] [Related]
24. Monocyte-derived influence on growth of normal human fibroblasts. The contribution of tumour necrosis factor to growth inhibition.
Austgulen R; Nissen-Meyer J; Degré M; Espevik T
Scand J Immunol; 1987 Aug; 26(2):175-85. PubMed ID: 3114873
[TBL] [Abstract][Full Text] [Related]
25. In vitro monocyte maturation in squamous carcinoma of the lung.
Dent RG; Cole P
Br J Cancer; 1981 Apr; 43(4):486-95. PubMed ID: 7236490
[TBL] [Abstract][Full Text] [Related]
26. A qualitative and quantitative study of monocytes in patients with malignant solid tumors.
Kjeldsberg CR; Pay GD
Cancer; 1978 Jun; 41(6):2236-41. PubMed ID: 657089
[TBL] [Abstract][Full Text] [Related]
27. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.
Estko M; Baumgartner S; Urech K; Kunz M; Regueiro U; Heusser P; Weissenstein U
BMC Complement Altern Med; 2015 Apr; 15():130. PubMed ID: 25902944
[TBL] [Abstract][Full Text] [Related]
28. In vitro influence of endotoxin on human mononuclear phagocyte structure and function. 2. Enhancement of the expression of cytoststic and cytolytic activity of normal and lymphokine-activated monocytes.
Hammerstrøm J
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):391-9. PubMed ID: 397718
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of monocyte complement receptor enhancement by low molecular weight material from human lung cancers.
Glass EJ; Abell CA; Kay AB
Clin Exp Immunol; 1981 Mar; 43(3):540-8. PubMed ID: 7285392
[TBL] [Abstract][Full Text] [Related]
30. In vitro response to Corynebacterium parvum of human effusion lymphocytes isolated from patients with malignant and benign disease.
Hammerstrøm J
Acta Pathol Microbiol Scand C; 1980 Aug; 88(4):211-8. PubMed ID: 7446130
[TBL] [Abstract][Full Text] [Related]
31. Human peripheral blood monocyte and bronchoalveolar macrophage cytotoxicity for cultured human lung tumor cells.
Swinburne S; Cole P
J Reticuloendothel Soc; 1982 Nov; 32(5):371-85. PubMed ID: 6761437
[TBL] [Abstract][Full Text] [Related]
32. Direct effects of Corynebacterium parvum and BCG on human monocyte-mediated tumour cell cytostasis in vitro.
Hammerstrøm J
Acta Pathol Microbiol Scand C; 1979 Aug; 87C(4):293-300. PubMed ID: 386712
[TBL] [Abstract][Full Text] [Related]
33. Dissociation between tumour cell cytostatic and immuno-suppressive capacity of human monocytes activated with lymphokines.
Unsgaard G; Hammerstrøm J; Lamvik J
Acta Pathol Microbiol Immunol Scand C; 1982 Apr; 90(2):73-9. PubMed ID: 7080839
[TBL] [Abstract][Full Text] [Related]
34. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
35. Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation.
Olsnes C; Stavang H; Brokstad K; Olofsson J; Aarstad HJ
BMC Immunol; 2009 Jan; 10():6. PubMed ID: 19175917
[TBL] [Abstract][Full Text] [Related]
36. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG
J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of human blood monocytes on the growth of human tumour cell lines in vitro.
Parry HJ; Rees RC
Cancer Immunol Immunother; 1992; 34(6):355-60. PubMed ID: 1563012
[TBL] [Abstract][Full Text] [Related]
38. Effects of thymosin and evidence of monocyte suppression of both T- and B-cell functions in two cases of 'common variable immunodeficiency'.
Arala-Chaves MP; Korn JH; Galbraith GM; Porto MT; Smith CL; Fudenberg HH
Scand J Immunol; 1982 Jan; 15(1):97-104. PubMed ID: 6978521
[TBL] [Abstract][Full Text] [Related]
39. Human monocyte-mediated cytotoxicity to K-562 cells: activation by lymphokines.
Hammerstrøm J
Scand J Immunol; 1979; 10(6):575-84. PubMed ID: 396667
[TBL] [Abstract][Full Text] [Related]
40. Elevated cytostatic activity of monocytes from cancer patients.
Mashiba H; Matsunaga K; Yagawa K; Nomura Y; Yoshinaga H; Furusawa M; Jimi S
Gan; 1981 Dec; 72(6):848-53. PubMed ID: 7341334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
